See How GRG Health Unlocked KOL Insights to Guide the Future of Atopic Dermatitis Treatment

GRG Health captured real-world insights from 30 senior dermatology KOLs across Japan, Saudi Arabia, and the UAE. The study uncovered key concerns around long-term efficacy, integration challenges, and limited awareness of T-cell depleting therapies in emerging markets. Higher pipeline awareness in Japan highlighted the value of clinical trial exposure and early academic engagement. These insights are already supporting more tailored launch strategies and informed stakeholder engagement for next-generation Atopic Dermatitis therapies.

Summary

See How GRG Health Unlocked KOL Insights to Guide the Future of Atopic Dermatitis Treatment

GRG Health conducted a multi-country quantitative study, engaging senior dermatology Key Opinion Leaders (KOLs) across Japan, Saudi Arabia, and the UAE. Through targeted outreach and structured research, we gathered strategic insights on treatment satisfaction, awareness of pipeline drugs, and evolving expectations in Atopic Dermatitis (AD) care.

Summary

See how GRG Health helped uncover unmet needs and regional adoption gaps to support smarter innovation in AD therapies.

A global pharmaceutical company partnered with GRG Health to explore how leading dermatologists perceive current AD treatments and how ready they are for the next wave of pipeline therapies.

The challenge? Variations in market maturity, limited real-world data, and inconsistent awareness of T-cell depleting mechanisms across key regions.

Using a KOL-focused approach, the study delivered:

 ✅ Insights from 30 senior dermatologists across Japan, KSA, and UAE
✅High unmet need for safer, longer-acting, and easier-to-administer therapies
✅Greater pipeline awareness in Japan due to academic trial exposure
✅Clear preference for non–T-cell depleting drugs and localized clinical data
✅Concerns over long-term cost, safety, and integration into clinical routines

These findings empowered the client to refine its medical strategy, build stronger regional engagement models, and align pipeline messaging with what KOLs truly value.

Want to know more?

Fill out the form to download the full case study and discover how GRG Health helps pharmaceutical brands engage experts, close adoption gaps, and shape product strategy with precision.